Venetoclax plus rituximab in relapsed chronic lymphocytic leukemia: 4-year results and evaluation of impact of genomic complexity and gene mutations from the MURANO phase III study

  1. Kater, A.P.
  2. Wu, J.Q.
  3. Kipps, T.
  4. Eichhorst, B.
  5. Hillmen, P.
  6. D'Rozario, J.
  7. Assouline, S.
  8. Owen, C.
  9. Robak, T.
  10. de la Serna, J.
  11. Jaeger, U.
  12. Cartron, G.
  13. Montillo, M.
  14. Dubois, J.
  15. Eldering, E.
  16. Mellink, C.
  17. van der Kevie-Kersemaekers, A.-M.
  18. Kim, S.Y.
  19. Chyla, B.
  20. Punnoose, E.
  21. Bolen, C.R.
  22. Assaf, Z.J.
  23. Jiang, Y.
  24. Wang, J.
  25. Lefebure, M.
  26. Boyer, M.
  27. Humphrey, K.
  28. Seymour, J.F.
  29. Erakutsi egile guztiak +
Aldizkaria:
Journal of Clinical Oncology

ISSN: 1527-7755,  0732-183X

Argitalpen urtea: 2020

Alea: 38

Zenbakia: 34

Orrialdeak: 4042-4054

Mota: Biltzar ekarpena

DOI: 10.1200/JCO.20.00948 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus